Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
MANTA Vascular Closure Device: Cardiovascular Risk Factors and Complications in a Single-Center Study
Session:
Sessão de Posters 26 - TAVI: acessos vasculares
Speaker:
Joana Guimarães
Congress:
CPC 2024
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.3 Non-coronary Cardiac Intervention
Session Type:
Cartazes
FP Number:
---
Authors:
Joana Guimarães; Eric Monteiro; Diogo Fernandes; Gonçalo Costa; Sofia Martinho; Elisabete Jorge; Vera Marinho; Marco Costa; Lino Gonçalves
Abstract
<p>BACKGROUND: Transcatheter aortic valve replacement (TAVR) involves large-bore arterial cannulation, often leading to significant bleeding and vascular complications. Collagen-based vascular closure devices (VCD), like MANTA VCD, can help address these issues. This study explores the correlation between cardiovascular risk factors and bleeding/vascular complications in MANTA VCD procedures.</p> <p>METHODS: A retrospective study at a large single-center analyzed TAVR patients with MANTA VCD closure between July 2020 and February 2022. Efficacy endpoints included immediate hemostasis and safety outcomes involved VARC-3 criteria for bleeding and vascular complications. Baseline characteristics investigated cardiovascular risk factor correlations.</p> <p>RESULTS: 245 consecutive TAVR patients with MANTA VCD closure were included. Successful closure occurred in 92.2% (n=226). Device failure (7.8%) resulted in one patient requiring secondary surgery (due to occlusion of the femoral artery unresolved with balloon dilatation). Per VARC-3, no major complications occurred; 8.6% of patients (n=21) had minor VARC-3 vascular complications. Minor bleeding at the primary access site (closed with MANTA) was 2.9% (n=7).</p> <p>Cardiovascular risk factors as coronary artery disease (CAD), arterial hypertension, and chronic kidney disease (CKD) correlated with bleeding/vascular complications. CAD patients (n=83) had a 13.4% complication rate, compared to 8.6% without CAD (n=162) with an odds ratio of 1.35 (95% CI 1.08 – 3.81, p < 0.040). Arterial hypertension (n=195) showed a 12.2% complication rate versus 7.1% without arterial hypertension (n=107) with an odds ratio of 3.44 (95% CI 1.02 – 11.64, p < 0.042). CKD patients (n=45) had a 20.0% complication rate versus 6.0% without CKD (n=200), odds ratio 8.45 (95% CI 2.63 – 27.16, p < 0.001).</p> <p>No significant differences occurred for other cardiovascular risk factors (peripheral vascular disease, atrial fibrillation, obesity, diabetes, smoking history, or chronic obstructive pulmonary disease).</p> <p>CONCLUSION: The MANTA vascular closure device proves to be a secure and efficient tool for closing arterial access in procedures like TAVR. Device failure was infrequent and rarely associated with severe complications. The presence of CAD, arterial hypertension and CKD is linked to an increased risk of bleeding and vascular complications according to VARC-3 criteria. To enhance outcomes, it is imperative to conduct additional multicenter studies to delve into the correlation between cardiovascular risk factors and complications in vascular access site closure.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site